• 1
    Parfitt AM 1984 The cellular basis of bone remodeling: The quantum concept reexamined in light of recent advances in the cell biology of bone. Calcif Tissue Int 36:S37S45.
  • 2
    Everts V, Delaisse JM, Korper W, Jansen DC, Tigchelaar-Gutter W, Saftig P, Beertsen W 2002 The bone lining cell: Its role in cleaning Howship's lacunae and initiating bone formation. J Bone Miner Res 17:7790.
  • 3
    Taichman RS, Reilly MJ, Emerson SG 1996 Human osteoblasts support human hematopoietic progenitor cells in in vitro bone marrow cultures. Blood 87:518524.
  • 4
    Hofbauer LC, Khosla S, Dunstan CR, Lacey DL, Boyle WJ, Riggs BL 2000 The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption. J Bone Miner Res 15:212.
  • 5
    Simmons PJ, Torok-Storb B 1991 Identification of stromal cell precursors in human bone marrow by a novel monoclonal antibody STRO-1. Blood 78:5562.
  • 6
    Gronthos S, Ohta S, Graves SE, Simmons PJ 1994 The STRO-1+ fraction of adult human bone marrow contains the osteogenic precursors. Blood 84:41644173.
  • 7
    Gronthos S, Zannettino ACW, Graves SE, Ohta S, Hay SJ, Simmons PJ 1999 Differential cell surface expression of the STRO-1 and alkaline phosphatase antigens on discrete developmental stages in primary cultures of human bone cells. J Bone Miner Res 14:4756.
  • 8
    Stewart K, Walsh S, Screen J, Jefferiss CM, Chainey J, Jordan GR, Beresford JN 1999 Further characterization of cells expressing STRO-1 in cultures of adult human bone marrow stromal cells. J Bone Miner Res 14:13451356.
  • 9
    Oyajobi BO, Lomri A, Hott M, Marie PJ 1999 Isolation and characterization of human clonogenic osteoblast progenitors immunoselected from fetal bone marrow stroma using STRO-1 monoclonal antibody. J Bone Miner Res 14:351361.
  • 10
    Encina NR, Billotte WG, Hofmann MC 1999 Immunomagnetic isolation of osteoprogenitors from human bone marrow stroma. Lab Invest 79:449457.
  • 11
    Dennis JE, Carbillet JP, Caplan AI, Charbord P 2002 The STRO-1+ marrow cell population is multipotential. Cells Tissues Organs 170:7382.
  • 12
    Parfitt AM 2000 The mechanism of coupling: A role for the vasculature. Bone 26:319323.
  • 13
    Theill LE, Boyle WJ, Penninger JM 2002 RANK-L and RANK: T cells, bone loss, and mammalian evolution. Annu Rev Immunol 20:795823.
  • 14
    Tsukii K, Shima N, Mochizuki S, Yamaguchi K, Kinosaki M, Yano K, Shibata O, Udagawa N, Yasuda H, Suda T, Higashio K 1998 Osteoclast differentiation factor mediates an essential signal for bone resorption induced by 1 alpha, 25-dihydroxyvitamin D3, prostaglandin E2, or parathyroid hormone in the microenvironment of bone. Biochem Biophys Res Commun 246:337341.
  • 15
    Lacey DL, Timms E, Tan HL, Kelley MJ, Dunstan CR, Burgess T, Elliott R, Colombero A, Elliott G, Scully S, Hsu H, Sullivan J, Hawkins N, Davy E, Capparelli C, Eli A, Qian YX, Kaufman S, Sarosi I, Shalhoub V, Senaldi G, Guo J, Delaney J, Boyle WJ 1998 Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 93:165176.
  • 16
    Yasuda H, Shima N, Nakagawa N, Yamaguchi K, Kinosaki M, Mochizuki S, Tomoyasu A, Yano K, Goto M, Murakami A, Tsuda E, Morinaga T, Higashio K, Udagawa N, Takahashi N, Suda T 1998 Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. Proc Natl Acad Sci USA 95:35973602.
  • 17
    Kong YY, Yoshida H, Sarosi I, Tan HL, Timms E, Capparelli C, Morony S, Oliveira-dos-Santos AJ, Van G, Itie A, Khoo W, Wakeham A, Dunstan CR, Lacey DL, Mak TW, Boyle WJ, Penninger JM 1999 OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature 397:315323.
  • 18
    Simonet WS, Lacey DL, Dunstan CR, Kelley M, Chang MS, Luthy R, Nguyen HQ, Wooden S, Bennett L, Boone T, Shimamoto G, DeRose M, Elliott R, Colombero A, Tan HL, Trail G, Sullivan J, Davy E, Bucay N, Renshaw-Gegg L, Hughes TM, Hill D, Pattison W, Campbell P, Sander S, Van G, Tarpley J, Derby P, Lee R, Boyle WJ 1997 Osteoprotegerin: A novel secreted protein involved in the regulation of bone density. Cell 89:309319.
  • 19
    Fazzalari NL, Kuliwaba JS, Atkins GJ, Forwood MR, Findlay DM 2001 The ratio of messenger RNA levels of receptor activator of nuclear factor kappaB ligand to osteoprotegerin correlates with bone remodeling indices in normal human cancellous bone but not in osteoarthritis. J Bone Miner Res 16:10151027.
  • 20
    Gori F, Hofbauer L, Dunstan CR, Spelsberg TC, Khosla S, Riggs BL 2000 The expression of osteoprotegerin and RANK ligand and the support of osteoclast formation by stromal-osteoblast lineage cells is developmentally regulated. Endocrinology 141:47684776.
  • 21
    Thomas GP, Baker SU, Eisman JA, Gardiner EM 2001 Changing RANKL/OPG mRNA expression in differentiating murine primary osteoblasts. J Endocrinol 170:451460.
  • 22
    Udagawa N, Takahashi N, Akatsu T, Sasaki T, Yamaguchi A, Kodama H, Martin TJ, Suda T 1989 The bone marrow-derived stromal cell lines MC3T3-G2/PA6 and ST2 support osteoclast-like cell differentiation in cocultures with mouse spleen cells. Endocrinology 125:18051813.
  • 23
    Fujikawa Y, Quinn JM, Sabokbar A, McGee JO, Athanasou NA 1996 The human osteoclast precursor circulates in the monocyte fraction. Endocrinology 137:40584060.
  • 24
    Haynes DR, Atkins GJ, Loric M, Crotti TN, Geary SM, Findlay DM 1999 Bidirectional signaling between stromal and hemopoietic cells regulates interleukin-1 expression during human osteoclast formation. Bone 25:269278.
  • 25
    Atkins GJ, Haynes DR, Geary SM, Loric M, Crotti TN, Findlay DM 2000 Coordinated cytokine expression by stromal and hematopoietic cells during human osteoclast formation. Bone 26:653661.
  • 26
    Horwood NJ, Elliott J, Martin TJ, Gillespie MT 1998 Osteotropic agents regulate the expression of osteoclast differentiation factor and osteoprotegerin in osteoblastic stromal cells. Endocrinology 139:47434746.
  • 27
    Kitazawa R, Kitazawa S, Maeda S 1999 Promoter structure of mouse RANKL/TRANCE/OPGL/ODF gene. Biochim Biophys Acta 1445:134141.
  • 28
    Hofbauer LC, Gori F, Riggs BL, Lacey DL, Dunstan CR, Spelsberg TC, Khosla S 1999 Stimulation of osteoprotegerin ligand and inhibition of osteoprotegerin production by glucocorticoids in human osteoblastic lineage cells: Potential paracrine mechanisms of glucocorticoid-induced osteoporosis. Endocrinology 140:43824389.
  • 29
    Byers RJ, Brown J, Brandwood C, Wood P, Staley W, Hainey L, Freemont AJ, Hoyland JA 1999 Osteoblastic differentiation and mRNA analysis of STRO-1-positive human bone marrow stromal cells using primary in vitro culture and poly (A) PCR. J Pathol 187:374381.
  • 30
    Buttery LD, Bourne S, Xynos JD, Wood H, Hughes FJ, Hughes SP, Episkopou V, Polak JM 2001 Differentiation of osteoblasts and in vitro bone formation from murine embryonic stem cells. Tissue Eng 7:8999.
  • 31
    Walsh S, Jordan GR, Jefferiss C, Stewart K, Beresford JN 2001 High concentrations of dexamethasone suppress the proliferation but not the differentiation or further maturation of human osteoblast precursors in vitro: Relevance to glucocorticoid-induced osteoporosis. Rheumatology 40:7483.
  • 32
    Lyons AB, Parish CR 1994 Determination of lymphocyte division by flow cytometry. J Immunol Methods 171:131137.
  • 33
    Atkins GJ, Haynes DR, Graves SE, Evdokiou A, Hay S, Bouralexis S, Findlay DM 2000 Expression of osteoclast differentiation signals by stromal elements of giant cell tumors. J Bone Miner Res 15:640649.
  • 34
    Owen TA, Aronow M, Shalhoub V, Barone LM, Wilming L, Tassinari MS, Kennedy MB, Pockwinse S, Lian JB, Stein GS 1990 Progressive development of the rat osteoblast phenotype in vitro: Reciprocal relationships in expression of genes associated with osteoblast proliferation and differentiation during formation of the bone extracellular matrix. J Cell Physiol 143:420430.
  • 35
    van Leeuwen JP, van Driel M, van den Bemd GJ, Pols HA 2001 Vitamin D control of osteoblast function and bone extracellular matrix mineralization. Crit Rev Eukaryot Gene Expr 11:199226.
  • 36
    Gurlek A, Kumar R 2001 Regulation of osteoblast growth by interactions between transforming growth factor-beta and 1alpha, 25-dihydroxyvitamin D3. Crit Rev Eukaryot Gene Expr 11:299317.
  • 37
    Siggelkow H, Rebenstorff K, Kurre W, Niedhart C, Engel I, Schulz H, Atkinson MJ, Hufner M 1999 Development of the osteoblast phenotype in primary human osteoblasts in culture: Comparison with rat calvarial cells in osteoblast differentiation. J Cell Biochem 75:2235.
  • 38
    Siggelkow H, Schulz H, Kaesler S, Benzler K, Atkinson MJ, Hufner M 1999 1, 25 dihydroxyvitamin-D3 attenuates the confluence-dependent differences in the osteoblast characteristic proteins alkaline phosphatase, procollagen I peptide, and osteocalcin. Calcif Tissue Int 64:414421.
  • 39
    Owen TA, Aronow MS, Barone LM, Bettencourt B, Stein GS, Lian JB 1991 Pleiotropic effects of vitamin D on osteoblast gene expression are related to the proliferative and differentiated state of the bone cell phenotype: Dependency upon basal levels of gene expression, duration of exposure, and bone matrix competency in normal rat osteoblast cultures. Endocrinology 128:14961504.
  • 40
    MacDonald PN, Baudino TA, Tokumaru H, Dowd DR, Zhang C 2001 Vitamin D receptor and nuclear receptor coactivators: Crucial interactions in vitamin D-mediated transcription. Steroids 66:171176.
  • 41
    Vidal NO, Brandstrom H, Jonsson KB, Ohlsson C 1998 Osteoprotegerin mRNA is expressed in primary human osteoblast-like cells: Down-regulation by glucocorticoids. J Endocrinol 159:191195.
  • 42
    Erben RG, Scutt AM, Miao D, Kollenkirchen U, Haberey M 1997 Short-term treatment of rats with high dose 1, 25-dihydroxyvitamin D3 stimulates bone formation and increases the number of osteoblast precursor cells in bone marrow. Endocrinology 138:46294635.
  • 43
    Erben RG, Mosekilde L, Thomsen JS, Weber K, Stahr K, Leyshon A, Smith SY, Phipps R 2002 Prevention of bone loss in ovariectomized rats by combined treatment with risedronate and 1, 25-dihydroxyvitamin D3. J Bone Miner Res 17:14981511.
  • 44
    Gardiner EM, Baldock PA, Thomas GP, Sims NA, Henderson NK, Hollis B, White CP, Sunn KL, Morrison NA, Walsh WR, Eisman JA 2000 Increased formation and decreased resorption of bone in mice with elevated vitamin D receptor in mature cells of the osteoblastic lineage. FASEB J 14:19081916.
  • 45
    Gallagher JC, Fowler SE, Detter JR, Sherman SS 2001 Combination treatment with estrogen and calcitriol in the prevention of age-related bone loss. J Clin Endocrinol Metab 86:36183628.
  • 46
    Weinstein RS, Chen JR, Powers CC, Stewart SA, Landes RD, Bellido T, Jilka RL, Parfitt AM, Manolagas SC 2002 Promotion of osteoclast survival and antagonism of bisphosphonate-induced osteoclast apoptosis by glucocorticoids. J Clin Invest 109:10411048.
  • 47
    Siggelkow H, Schenck M, Rohde M, Viereck V, Tauber S, Atkinson MJ, Hufner M 2002 Prolonged culture of HOS 58 human osteosarcoma cells with 1, 25-(OH)2-D3 TGF-beta, and dexamethasone reveals physiological regulation of alkaline phosphatase, dissociated osteocalcin gene expression, and protein synthesis and lack of mineralization. J Cell Biochem 85:279294.
  • 48
    Canalis E, Giustina A 2001 Glucocorticoid-induced osteoporosis: Summary of a workshop. J Clin Endocrinol Metab 86:56815685.
  • 49
    Doherty MJ, Ashton BA, Walsh S, Beresford JN, Grant ME, Canfield AE 1998 Vascular pericytes express osteogenic potential in vitro and in vivo. J Bone Miner Res 13:828838.